Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivana Yen

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Nature|February 5, 2010
RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growthGeorgia Hatzivassiliou, Kyung Song, Ivana Yen, et al.
ACS Medicinal Chemistry Letters|May 31, 2021
Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a Pyridopyridazinone pan-RAF Kinase InhibitorMalcolm P Huestis, Matthew R Durk, Charles Eigenbrot, et al.
ACS Medicinal Chemistry Letters|January 29, 2016
Pyridones as Highly Selective, Noncovalent Inhibitors of T790M Double Mutants of EGFRMarian C Bryan, Daniel J Burdick, Bryan K Chan, et al.
Cell Reports|February 9, 2022
CRAF dimerization with ARAF regulates KRAS-driven tumor growthAvinashnarayan Venkatanarayan, Jason Liang, Ivana Yen, et al.
Bioorganic & Medicinal Chemistry Letters|May 1, 2013
Identification of substituted 2-thio-6-oxo-1,6-dihydropyrimidines as inhibitors of human lactate dehydrogenasePeter S Dragovich, Benjamin P Fauber, Laura B Corson, et al.
Journal of Medicinal Chemistry|March 29, 2021
Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a 5-Fluoro-4-(3<i>H</i>)-quinazolinone Aryl Urea pan-RAF Kinase InhibitorMalcolm P Huestis, Darlene Dela Cruz, Antonio G DiPasquale, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2014
Optimization of 5-(2,6-dichlorophenyl)-3-hydroxy-2-mercaptocyclohex-2-enones as potent inhibitors of human lactate dehydrogenaseSharada Labadie, Peter S Dragovich, Jinhua Chen, et al.
Journal of Medicinal Chemistry|November 11, 2014
Discovery of selective and noncovalent diaminopyrimidine-based inhibitors of epidermal growth factor receptor containing the T790M resistance mutationEmily J Hanan, Charles Eigenbrot, Marian C Bryan, et al.
Journal of Medicinal Chemistry|March 12, 2016
Correction to Noncovalent Mutant Selective Epidermal Growth Factor Receptor Inhibitors: A Lead Optimization Case StudyRobert Heald, Krista K Bowman, Marian C Bryan, et al.
Journal of Medicinal Chemistry|October 13, 2015
Noncovalent Mutant Selective Epidermal Growth Factor Receptor Inhibitors: A Lead Optimization Case StudyRobert Heald, Krista K Bowman, Marian C Bryan, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Nature|February 5, 2010
RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growthGeorgia Hatzivassiliou, Kyung Song, Ivana Yen, et al.
ACS Medicinal Chemistry Letters|May 31, 2021
Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a Pyridopyridazinone pan-RAF Kinase InhibitorMalcolm P Huestis, Matthew R Durk, Charles Eigenbrot, et al.
ACS Medicinal Chemistry Letters|January 29, 2016
Pyridones as Highly Selective, Noncovalent Inhibitors of T790M Double Mutants of EGFRMarian C Bryan, Daniel J Burdick, Bryan K Chan, et al.
Cell Reports|February 9, 2022
CRAF dimerization with ARAF regulates KRAS-driven tumor growthAvinashnarayan Venkatanarayan, Jason Liang, Ivana Yen, et al.
Bioorganic & Medicinal Chemistry Letters|May 1, 2013
Identification of substituted 2-thio-6-oxo-1,6-dihydropyrimidines as inhibitors of human lactate dehydrogenasePeter S Dragovich, Benjamin P Fauber, Laura B Corson, et al.
Journal of Medicinal Chemistry|March 29, 2021
Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a 5-Fluoro-4-(3<i>H</i>)-quinazolinone Aryl Urea pan-RAF Kinase InhibitorMalcolm P Huestis, Darlene Dela Cruz, Antonio G DiPasquale, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2014
Optimization of 5-(2,6-dichlorophenyl)-3-hydroxy-2-mercaptocyclohex-2-enones as potent inhibitors of human lactate dehydrogenaseSharada Labadie, Peter S Dragovich, Jinhua Chen, et al.
Journal of Medicinal Chemistry|November 11, 2014
Discovery of selective and noncovalent diaminopyrimidine-based inhibitors of epidermal growth factor receptor containing the T790M resistance mutationEmily J Hanan, Charles Eigenbrot, Marian C Bryan, et al.
Journal of Medicinal Chemistry|March 12, 2016
Correction to Noncovalent Mutant Selective Epidermal Growth Factor Receptor Inhibitors: A Lead Optimization Case StudyRobert Heald, Krista K Bowman, Marian C Bryan, et al.
Journal of Medicinal Chemistry|October 13, 2015
Noncovalent Mutant Selective Epidermal Growth Factor Receptor Inhibitors: A Lead Optimization Case StudyRobert Heald, Krista K Bowman, Marian C Bryan, et al.
Pageof 3